These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3548954)

  • 1. Noradrenergic and cholinergic agents in Korsakoff's syndrome.
    O'Donnell VM; Pitts WM; Fann WE
    Clin Neuropharmacol; 1986; 9(1):65-70. PubMed ID: 3548954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Korsakoff's syndrome, cognition and clonidine.
    O'Carroll RE; Moffoot A; Ebmeier KP; Murray C; Goodwin GM
    Psychol Med; 1993 May; 23(2):341-7. PubMed ID: 8332651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory enhancement in Korsakoff's psychosis by clonidine: further evidence for a noradrenergic deficit.
    McEntee WJ; Mair RG
    Ann Neurol; 1980 May; 7(5):466-70. PubMed ID: 6994586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of desglycinamide-arginine-vasopressin (DGAVP) on memory in patients with korsakoff's syndrome.
    Laczi F; Van Ree JM; Balogh L; Szász A; Járdánházy T; Wágner A; Gáspár L; Valkusz Z; Dobranovics I; Szilárd J
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):177-82. PubMed ID: 6637330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level.
    Beller SA; Overall JE; Swann AC
    Psychopharmacology (Berl); 1985; 87(2):147-51. PubMed ID: 3931138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive enhancement in Korsakoff's psychosis by clonidine: a comparison with L-dopa and ephedrine.
    Mair RG; McEntee WJ
    Psychopharmacology (Berl); 1986; 88(3):374-80. PubMed ID: 3083458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective pharmacotherapy of alcoholic amnestic disorder with fluvoxamine. Preliminary findings.
    Martin PR; Adinoff B; Eckardt MJ; Stapleton JM; Bone GA; Rubinow DR; Lane EA; Linnoila M
    Arch Gen Psychiatry; 1989 Jul; 46(7):617-21. PubMed ID: 2472126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory effect of DL-threo-3,4-dihydroxyphenylserine (DOPS) in human Korsakoff's disease.
    Langlais PJ; Mair RG; Whalen PJ; McCourt W; McEntee WJ
    Psychopharmacology (Berl); 1988; 95(2):250-4. PubMed ID: 3137605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.
    Davis KL; Berger PA
    Biol Psychiatry; 1978 Feb; 13(1):23-49. PubMed ID: 146524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Korsakoff's syndrome: radiological (CT) findings and neuropsychological correlates.
    Shimamura AP; Jernigan TL; Squire LR
    J Neurosci; 1988 Nov; 8(11):4400-10. PubMed ID: 3183726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcoholic blackouts and Korsakoff's syndrome.
    Goodwin DW; Hill SY; Hopper S
    Adv Exp Med Biol; 1975; 59():585-93. PubMed ID: 1180160
    [No Abstract]   [Full Text] [Related]  

  • 12. Rates of forgetting in Alzheimer-type dementia and Korsakoff's syndrome.
    Kopelman MD
    Neuropsychologia; 1985; 23(5):623-38. PubMed ID: 4058708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.
    Davis KL; Mohs RC
    Am J Psychiatry; 1982 Nov; 139(11):1421-4. PubMed ID: 6753611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autobiographical memory loss and confabulation in Korsakoff's syndrome: a case report.
    Dalla Barba G; Cipolotti L; Denes G
    Cortex; 1990 Dec; 26(4):525-34. PubMed ID: 2081390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of rehearsal in the short-term memory performance of patients with Korsakoff's and Huntington's disease.
    Meudell P; Butters N; Montgomery K
    Neuropsychologia; 1978; 16(4):507-10. PubMed ID: 151243
    [No Abstract]   [Full Text] [Related]  

  • 16. Preservation of cognitive procedural memory in a case of Korsakoff's syndrome: methodological and theoretical insights.
    Beaunieux H; Desgranges B; Lalevée C; de la Sayette V; Lechevalier B; Eustache F
    Percept Mot Skills; 1998 Jun; 86(3 Pt 2):1267-87. PubMed ID: 9700804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory decline in the aged: treatment with lecithin and physostigmine.
    Drachman DA; Glosser G; Fleming P; Longenecker G
    Neurology; 1982 Sep; 32(9):944-50. PubMed ID: 6287359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term administration of oral physostigmine in Alzheimer's disease.
    Stern Y; Sano M; Mayeux R
    Neurology; 1988 Dec; 38(12):1837-41. PubMed ID: 3057398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinomimetics and memory. The effect of choline chloride.
    Davis KL; Mohs RC; Tinklenberg JR; Hollister LE; Pfefferbaum A; Kopell BS
    Arch Neurol; 1980 Jan; 37(1):49-52. PubMed ID: 7350901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intact verbal and nonverbal short-term memory following damage to the human hippocampus.
    Cave CB; Squire LR
    Hippocampus; 1992 Apr; 2(2):151-63. PubMed ID: 1308180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.